SUMMARY A case is presented in which a histologically proven prolactin secreting pituitary macroadenoma was associated with a large suprasellar craniopharyngioma. The pre-operative prolactin concentration was 8180mU/l. Although hyperprolactinaemia up to 3000mU/l in patients with a craniopharyngioma is usually due to stalk compression, greater values may indicate an associated prolactinoma.
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Craniopharyngioma may be associated with moderate hyperprolactinaemia, galactorrhoea and disturbance of the hypothalamo-pituitary-gonadal axis.' 4 However, in these cases as serum prolactin concentrations are usually less than 3000 mU/l (150ng/ml) and histo-pathological studies do not show prolactin secreting adenomata, the elevated levels are probably due to stalk compression.5 We report the first case in which a large suprasellar craniopharyngioma was associated with a prolactin secreting pituitary adenoma.
Case report
A 61-year-old man presented with a 9 month history of gradually deteriorating vision and difficulty with lateral vision while driving. In addition, he had noted reduced libido for 10 years, intermittent headaches for 2 years and cold intolerance for 2 months. He shaved daily and had no other symptoms suggestive of endocrine dysfunction. Hypertension had been diagnosed 7 years previously and treated with oxprenolol. His previous health had otherwise been satisfactory. There was a family history of ischaemic heart disease but not of neurological or endocrinological problems.
Examination revealed a corrected visual acuity of N/2 on the right and N/14 on the left, a bitemporal hemianopia, with a left lower quadrantic nasal field defect and bilateral pallor of the optic discs. He was moderately obese with nor-mal secondary sexual characteristics and had no galactorrhoea or signs of hypothyroidism or hypoadrenalism. His right brachial blood pressure was 150/100mm Hg without postural fall and examination of remaining systems was normal.
Initial investigations showed an increased cardiac diameter of 16cm without evidence of pulmonary oedema, a normal 12 lead ECG and normal plasma electrolytes, serum calcium, blood glucose and serum protein concentrations. Tests of endocrine function showed a serum prolactin concentration of 8180 mU/1 (normal range for males < 150) and a serum testosterone of 5-6 nmol/l (normal range for males 10-38). The results of other endocrine investigations were normal (table). A plain skull radiograph was normal without evidence of pituitary fossa enlargement or abnormal calcification and a CT brain scan revealed a non-enhancing, low density area in the left suprasellar region, with a normal sella. Bilateral carotid angiography showed an avascular space-occupying lesion in the suprasellar region with elevation and posterior displacement of the anterior cerebral arteries. As the radiological findings were consistent with a craniopharyngioma and the results of endocrine function tests were unavailable at that stage the lesion was explored, under hydrocortisone cover, using a subfrontal approach via a coronal flap. This revealed a cystic craniopharyngioma, confirmed histologically, which was subtotally resected leaving a fragment of the capsule which was adherent to the optic nerve. No tumour was seen arising from the sella.
Following an uneventful post-operative recovery there was a progressive improvement in his visual fields, although investigation 6 weeks later showed that the serum prolactin remained elevated at 5650 mU/l (table).
However, 2 months after operation his visual acuity deteriorated from N2 on the right and N14 on the left, to hypothalamus, pituitary stalk and gland. The cut surface revealed a large, pale multicystic tumour mass up to 2-5cm diameter in the suprasellar region, compressing the third ventricle and adherent to the optic nerve and carotid artery. The pituitary stalk appeared normal and the gland was compressed around a soft intrasellar tumour, part of which was removed for separate embedding (fig 1) . Histological sections showed the suprasellar tumour to be residual craniopharyngioma with typical anastomosing islands of basaloid cells around stellate reticulum. Squamous metaplasia, keratinisation, calcification and cystic degeneration were present. The craniopharyngioma extended around the left optic nerve and carotid artery but did not involve the pituitary stalk. There was a compressed rim of pituitary gland around an adenoma which, despite autolysis, showed rather uniform chromophobe cells arranged in a sinusoidal pattern (fig 2a) . Immunocytochemical staining for prolactin using the peroxidaseantiperoxidase method on formalin-fixed paraffin embedded tissue was performed with the usual positive and negative controls to confirm specificityAntense granular cytoplasmic positivity was seen in most of the cells of the adenoma (fig 2b) . Scattered positive cells were noted in the rim of normal pituitary. The craniopharyngioma was totally negative for prolactin.
Discussion
Two previous reports have described the association of a histologically proven Rathke's pouch cyst, hyperprolactinaemia and a pituitary tumour with positive immunoperoxidase staining for prolactin. In the first case amenorrhoea, a serum prolactin concentration of 4580 mU/l and pituitary fossa enlargement were due to a large Rathke's pouch cyst within the fossa and a prolactin secreting tumour.6 In the second amenorrhoea, a serum prolactin concentration of 1600 mU/I and a radiologically normal pituitary fossa were due to a "transitional cell tumour" of the pituitary gland which was noted to have features of both a Rathke's pouch cyst and a pituitary adenoma.7 However, the association reported here of a large suprasellar craniopharyngioma, marked hyperprolactinaemia and a histologically proven prolactin secreting pituitary macroadenoma has not been previously described. Thus, although hyperprolactinaemia of less than 3000 mU/l, with or without disturbance of the hypothalamo-pituitary-gonadal axis, is frequently seen in patients with suprasellar tumours and is not associated with a prolactin secreting tumour, the coincidence of a prolactinoma should be considered when there is more marked elevation of the serum prolactin concentration. We thank Dr OM Edwards and Mr AE Holmes for allowing us to report their patient. We are also indebted to Dr TD Hawkins for his expert neuroradiological advice.
